Monday May 13 | BioSpace
Telik, Inc. Announces First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! PALO ALTO, Calif., May 10, 2013 /PRNewswire/ -- Telik, Inc.
Telik Announces First Quarter 2013 Financial Results
Telik, Inc. today reported financial results for the first quarter ended March 31, 2013.
Telik: A Possible Investment, But Only After Much Consideration
Development-stage small pharmaceuticals developing novel and promising therapies to treat cancer and other large market disease indications are among the most sought after investments for many risk averse investors who are aware of the upside potential and downside risks for which the sector is known.
Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance
Telik, Inc. reported a net loss of $1.8 million, or $0.66 per share, for the three months ended December 31, 2012, compared with a net loss of $2.5 million, or $1.38 per share, for the comparable period in 2011.